Traditional, Hybrid Or Decentralized: What Actually Works?

Choosing the right clinical trial delivery model is no longer a simple decision between traditional and decentralized approaches. Today’s studies must balance patient accessibility, operational efficiency, data quality, and protocol requirements to improve recruitment, retention, and overall trial success. As sponsors seek more diverse and representative patient populations, the limitations of site-based research and the challenges of fully remote participation have become increasingly apparent. 

A growing focus on hybrid and community-based models is creating new opportunities to bring research closer to patients while preserving the oversight and support needed for high-quality study execution. Factors such as disease burden, mobility limitations, caregiver involvement, geography, and treatment complexity all influence which approach will be most effective. Across therapeutic areas including CNS disorders, oncology, obesity, and rare diseases, patient-centered trial design is emerging as a critical driver of both participant experience and study outcomes. 

Explore how delivery strategies can be tailored to meet the needs of patients and strengthen clinical research performance.